JBN Medical Diagnostic Services Inc.
Burlington, Ontario, Canada
Medical clinic in Burlington, Ontario
301-2951 Walker's Line, Burlington, ON L7M 4Y1
About JBN Medical Diagnostic Services Inc.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
3
Genentech, Inc.
2
Hoffmann-La Roche
2
Pfizer
2
Allergy Therapeutics
1
Biogen
1
Eisai Inc.
1
Kowa Research Institute, Inc.
1
Clinical Trials at JBN Medical Diagnostic Services Inc.
During the past decade, JBN Medical Diagnostic Services Inc. conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 9 clinical trials were completed, i.e. on
average, 225% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (ABBY)
2011-04-30
2014-02-28
Completed
448
A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
2012-10-24
2015-06-12
Completed
542
A Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With Crenezumab
2012-12-07
2017-02-08
Completed
360
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
2013-07-10
2018-01-18
Completed
6,991
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors
2014-01-24
2018-05-14
Completed
14,673
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "JBN Medical Diagnostic Services Inc." #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Genentech, Inc." with 2 trials
sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Allergy Therapeutics"
with 2 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "JBN Medical Diagnostic Services Inc."
#1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator and "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at JBN Medical Diagnostic Services Inc.
According to Clinical.Site data, the most researched conditions in "JBN Medical Diagnostic Services Inc." are
"Alzheimer's Disease" (5 trials), "Cardiovascular Disease" (3 trials), "Heart Failure" (2 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Dyslipidemia" (1 trials). Many other conditions were trialed in "JBN Medical Diagnostic Services Inc." in a lesser frequency.
Clinical Trials Intervention Types at JBN Medical Diagnostic Services Inc.
Most popular intervention types in "JBN Medical Diagnostic Services Inc." are "Drug" (12 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Empagliflozin" (2 trials), "bococizumab (PF-04950615)" (2 trials), "Aducanumab (BIIB037)" (1 trials) and "Crenezumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at JBN Medical Diagnostic Services Inc.
The vast majority of trials in "JBN Medical Diagnostic Services Inc." are
13 trials for "All" genders.
Clinical Trials Status at JBN Medical Diagnostic Services Inc.
Currently, there are NaN active trials in "JBN Medical Diagnostic Services Inc.".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in JBN Medical Diagnostic Services Inc.,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in JBN Medical Diagnostic Services Inc., 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".